Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
William J.J. Finlay & Alexey A. Lugovskoy. (2019) De novo discovery of antibody drugs – great promise demands scrutiny. mAbs 11:5, pages 809-811.
Read now
Read now
Bram G. Sengers, Sean McGinty, Fatma Z. Nouri, Maryam Argungu, Emma Hawkins, Aymen Hadji, Andrew Weber, Adam Taylor & Armin Sepp. (2016) Modeling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion. mAbs 8:5, pages 905-915.
Read now
Read now
Jin Niu, Weirong Wang & Daniele Ouellet. Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities. Expert Review of Clinical Pharmacology 0:0, pages 1-14.
Read now
Read now
Articles from other publishers (7)
Rajbharan Yadav, Siddharth Sukumaran, Tanja S. Zabka, Jinze Li, Amy Oldendorp, Gary Morrow, Arthur Reyes, Melissa Cheu, Jessica Li, Jeffrey J. Wallin, Siao Tsai, Laura Sun, Peiyin Wang, Diego Ellerman, Christoph Spiess, Andy Polson, Eric G. Stefanich, Amrita V. Kamath & Meric A. Ovacik. (2022) Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies. Pharmaceutics 14:5, pages 970.
Crossref
Crossref
Yu Tang & Yanguang Cao. (2021) Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions. Pharmaceutics 13:3, pages 422.
Crossref
Crossref
John P. Gibbs, Theresa Yuraszeck, Carla Biesdorf, Yang Xu & Sreeneeranj Kasichayanula. (2020) Informing Development of Bispecific Antibodies Using Physiologically Based Pharmacokinetic‐Pharmacodynamic Models: Current Capabilities and Future Opportunities. The Journal of Clinical Pharmacology 60:S1.
Crossref
Crossref
Alison Betts & Piet H. van der Graaf. (2020) Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology. Clinical Pharmacology & Therapeutics 108:3, pages 528-541.
Crossref
Crossref
Sonja Kunstmann, Olof Engström, Marko Wehle, Göran Widmalm, Mark Santer & Stefanie Barbirz. (2020)
Increasing the Affinity of an O‐Antigen Polysaccharide Binding Site in
Shigella flexneri
Bacteriophage Sf6 Tailspike Protein
. Chemistry – A European Journal 26:32, pages 7263-7273.
Crossref
Crossref
Johannes Schropp, Antari Khot, Dhaval K. Shah & Gilbert Koch. (2019) Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy. CPT: Pharmacometrics & Systems Pharmacology 8:3, pages 177-187.
Crossref
Crossref
A Trivedi, S Stienen, M Zhu, H Li, T Yuraszeck, J Gibbs, T Heath, R Loberg & S Kasichayanula. (2017) Clinical Pharmacology and Translational Aspects of Bispecific Antibodies. Clinical and Translational Science 10:3, pages 147-162.
Crossref
Crossref